when does the semaglutide patent expire Heavy Price of GLP-1 Drugs – I-MAK Novo Nordisk patent expiry opens

"That is happening because the patient population eligible for this medication is so large

In the unadjusted post hoc results, there were no significant differences in the proportion of patients with PDC 80% at day 180 or day 360 for semaglutide QW (61.9% and 59.2%, respectively) compared with dulaglutide (66.6% [ p = 0.06] and 52.2% [ p = 0.24], respectively)

Int J Biochem Cell Biol 2007

Protect all peptides from light and temperature fluctuations

Assess and document the patients sensory and motor function, including paresthesias, burning sensations, and numbness in the lower extremities, to establish a baseline and monitor the progression of peripheral neuropathy